pretickt

When does Twist Bioscience report earnings?

Twist Bioscience Corporation · end-of-day data as of Nov 13, 2026

Twist Bioscience
TWST · $7.35B
$111.60-2.3%
Nov 13, 2026 · close
$150$200SepOctNov9:3016:003 months -3.9%Nov 13 · close
▲ 3
  • PT$145.70 +30.6%
  • ConsensusBuy · 13
  • Sector▲ +15.9%
Neutral
  • Earnings in80d
  • RSI38
  • Support-50.2%
  • Resistance+55.4%
  • Off 52w high-49.2%
  • Volume0.8x
  • Bollingerlower half
  • News1.00
  • Trendsideways
  • 52w range$23–$220
  • ATR+15.1%
  • Off ATH-49.2%
▼ 4
  • Insiders-$99.86M
  • MAs1 of 4
  • MA20×50Death 9d ago
  • MACD-3.21

Updates with the 15-min delayed price. Not a forecast or investment advice.

Twist Bioscience TWST reports its next earnings on Monday, Feb 1, 2027, before the open, an estimated date the company has not confirmed yet. Analysts expect EPS of -$0.39 on revenue of $131M. Twist Bioscience beat the EPS estimate in 4 of its last 8 reports, and the stock moved ±8.5% on average the session after. The last report, on Nov 12, 2026: EPS of -$0.32 against -$0.39 expected and revenue of $127M against $124M; the stock fell 6.8% the next session.

The stock around its reports

⇔⇕$35.91$88.36$141$193Nov 24Apr 25Sep 25Feb 26Jul 26Dec 26EEEEEEEAAEEE

Last close $111.60 · +136.0% over 2y · E earnings · D dividend · S split · A analyst rating change

Quarterly results

Q4 FY2026: Revenue +27.9% year over year, operating margin -25.0%.

RevenueFree cash flow
Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026
Q4 FY2026Sep 30, 2026$127M-0.31—53.1%-25.0%-16.3%
Q3 FY2026Jun 30, 2026$118M-0.56-$8.55M52.8%-30.6%-29.6%
Q2 FY2026Mar 31, 2026$111M-0.71-$25.55M51.6%-34.9%-39.8%
Q1 FY2026Dec 31, 2025$104M-0.50-$34.79M52.0%-31.7%-29.4%
Q4 FY2025Sep 30, 2025$99.01M-0.45-$24.24M51.3%-30.2%-27.4%
Q3 FY2025Jun 30, 2025$96.06M0.33-$10.56M53.4%-31.4%21.2%
Q2 FY2025Mar 31, 2025$92.79M-0.66-$17.13M49.6%-44.8%-42.4%
Q1 FY2025Dec 31, 2024$88.71M-0.53-$23.7M48.3%-39.1%-35.6%